NEW YORK (GenomeWeb) – A team led by researchers in Germany has tracked down copy number profiles that appear to correspond to poorer-than-usual outcomes in individuals with a form of liver cancer called intrahepatic cholangiocarcinoma (iCCA).

Using genome-wide array comparative genomic hybridization, the researchers searched for informative copy number alterations in 37 primary iCCA samples and more than a dozen matched lymph node metastases. Prior research suggested that lymph node metastases coincided with significantly poorer survival times in iCCA patients, they noted.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.

Oct
25
Sponsored by
Roche

This webinar will detail a comprehensive strategy that a lab has put in place to evaluate  NGS oncology assays for genomic tumor profiling of plasma and tissue samples.